Placebo + ABT-719

Phase 2Terminated

0 views this week 0 watching💤 Quiet

Interest: 27/100

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

Phase 2

Phase 3

Approved

Indication / Disease

Cardiothoracic Surgery

Conditions

Cardiothoracic Surgery, Vascular Surgery

Trial Timeline

May 1, 2013 → May 1, 2014

NCT ID

NCT01897519

About Placebo + ABT-719

Placebo + ABT-719 is a phase 2 stage product being developed by AbbVie for Cardiothoracic Surgery. The current trial status is terminated. This product is registered under clinical trial identifier NCT01897519. Target conditions include Cardiothoracic Surgery, Vascular Surgery.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (1)

NCT ID	Phase	Status	Start	Completion	Indication
NCT01897519	Phase 2	Terminated	May 1, 2013	May 1, 2014	Cardiothoracic Surgery